This study examines characteristics of 90 female sexual offenders based on offense and personality traits. The study uses latent profile analysis to identify groups of female sex offenders who are similar to one another and different from participants in other groups. Results using the Personality Assessment Inventory (PAI) indicate that there were three classes of offenders that differed with respect to the severity of their psychopathology. Upon analysis of predictors such as demographic information, offense characteristics, selected Trauma Symptom Inventory scores, Static-99 scores, abuse history, and PAI supplemental scales, several factors predicted group membership. These included marital status, sexual abuse in adulthood, and interpersonal relationship styles. Implications for assessment and treatment of female sex offenders are discussed.
Purpose – The purpose of this paper is to describe the experience of a southern English young offenders institution in developing and implementing standards to improve awareness and care of prisoners with autistic spectrum disorders (ASD). Design/methodology/approach – Some contextual factors driving the project are discussed, the multi-agency process involved in the development and implementation of the standards is described and recommendations are made regarding implementation of the standards in other settings. Findings – It is expected that successful implementation of the standards will reduce the level of distress and difficulty experienced by people with ASD who find themselves in custody, it will also improve the prison’s ability to meet the needs of prisoners with ASD and thereby improve rehabilitation and reduce any adverse impact on everyday operational processes. Demonstrating success in meeting the standards will enable the prison to achieve accreditation by the National Autistic Society. In March 2015 the prisons minister encouraged all prisons to follow this approach and this will have practice and resource implications. Originality/value – This paper describes a clear framework which prisons can use to work systematically towards achieving good practice in addressing the needs of prisoners with ASD. It will enable prisons to meet the duties imposed on them by the Autism Act, 2009 and the Equalities Act, 2010.
Purpose We conducted a retrospective review following concerns involving a suspected increase in the requirement for surgical re-exploration for hematoma evacuation when ketorolac was administered perioperatively in patients undergoing reduction mammoplasty. Methods Following ethics approval, a retrospective chart review was conducted of all patients who underwent reduction mammoplasty at our two institutions from the time ketorolac became available in 2004 until surgeons requested its use discontinued in 2007. The data we collected included patient demographics, ketorolac administration, requirement for surgical re-exploration, documented hematoma formation not requiring surgical re-exploration, and excessive bleeding in the perioperative period. Three hundred and seventy-nine patient records were reviewed; 127 of the patients received a single intravenous dose of ketorolac (15 or 30 mg), and 252 of the patients did not receive ketorolac.Results Patients who received ketorolac were at an increased risk of requiring surgical re-exploration for hematoma evacuation (relative risk [RR] = 3.6; 95% confidence interval [CI], 1.4 to 9.6) and hematoma formation not requiring re-exploration (RR = 2.2; 95% CI,
Residual paralysis is common at tracheal extubation and PACU arrival, despite qualitative neuromuscular monitoring and the use of neostigmine. More effective detection and management of NMB is needed to reduce the risks associated with residual NMB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.